Endogenous opioids implicated in the dynamics of experimental drug addiction: an in vivo autoradiographic analysis.
Endogenous opioids have been implicated in the neurobiological mechanisms underlying drug addiction. Although some information is available concerning effects of abused drugs on the endogenous opioid systems, the interpretation of these effects is hampered because data on the actual changes in the endogenous opioids during the dynamics of the drug addiction are lacking. The present report deals with changes in endogenous opioid activity before and after the daily self-administration session in rats offered cocaine or ethanol, using an in vivo autoradiographic receptor occupancy procedure. In separate saline-controlled experiments drug-naive rats were allowed to intravenously self-administer cocaine (30 microg/infusion) and ethanol (0.05%) for five consecutive daily sessions of 6 h. Immediately following the last session on day 5 or just before a scheduled next daily session on day 6, the rats were injected with [3H]diprenorphine and subsequently prepared for autoradiography. Decreased [3H]diprenorphine binding was observed throughout the subcortical brain after the daily session in cocaine, but hardly in animals self-administering ethanol. These changes are thought to reflect a direct or an indirect effect of the drug on endogenous opioid systems. Before the daily session, the [3H]diprenorphine binding was decreased in restricted areas of the mesocorticolimbic system and of the thalamus in both cocaine and ethanol self-administering animals. These data suggest that release of endogenous opioids at the time the desire for cocaine or ethanol is high, which may be pertinent for drug-induced craving and relapse of drug addicts.
Gerrits
M A
MA
Department of Medical Pharmacology, Rudolf Magnus Institute for Neurosciences, Utrecht University, The Netherlands.
Wiegant
V M
VM
Van Ree
J M
JM
D000437:Alcoholism / Q000378:metabolism*; D000818:Animals; D001345:Autoradiography / Q000379:methods; D001921:Brain / Q000378:metabolism*; D003042:Cocaine / Q000008:administration & dosage*; D019970:Cocaine-Related Disorders / Q000378:metabolism*; D004174:Diprenorphine / Q000493:pharmacokinetics*; D004723:Endorphins / Q000378:metabolism*; D000431:Ethanol / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D008032:Limbic System / Q000378:metabolism; D008297:Male; D009928:Organ Specificity; D051381:Rats; D017208:Rats, Wistar; D012646:Self Administration; D013788:Thalamus / Q000378:metabolism; D014316:Tritium
D004723:Endorphins; D014316:Tritium; D004174:Diprenorphine; D000431:Ethanol; D003042:Cocaine